• Home
  • About Us
  • Blog
  • Contact Us

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Uptravi is Approved for PAH Treatment
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Congenital Heart Disease
    • Eisenmenger’s Syndrome
    • Update on Management of PAH-CHD
    • Congenital Heart Disease & Sleep Apnea
    • Complex Congenital Heart Disease
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers

Update on the Implanted Remodulin Pump

April 10, 2017 By Dr. Jeremy Feldman

updateThis week we learned that the much-awaited arrival of the Implanted Pump System for Remodulin would be further delayed.  The FDA did not grant Medtronic and United Therapeutics approval.  Details are scant but the announcement indicated that the device might be approved in the beginning of 2018.

PAH Patients and doctors alike were let down by the delay.  The delay does not mean that the device will not get approved.  My advice is to remain positive and continue on your existing therapies.  We remain optimistic that in the not-to-distant future we will be able to deliver the benefits of Remodulin without site pain or external catheters.

Filed Under: Pulmonary Hypertension Treatments

  • Facebook
  • Google+
  • RSS
  • Twitter

Get Our Newsletter!

Advertisement

Popular Posts

Second Opinions

Second Opinions

By Dr. Jeremy Feldman

I can’t tell you how frequently my patients ask if their doctor will be offended if the patient goes to a different

Who’s Who at your Pulmonary Hypertension Center

Who’s Who at your Pulmonary Hypertension Center

By Dr. Jeremy Feldman

The first visit at a PH center can be very overwhelming. Many patients receive the news that they have a serious life

Advertisement

The Doctor is In

FAQ

Featured Content

Pulmonary Hypertension Centers

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Research, Life Expectancy & Prognosis for PH

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

good news in pah

Recent Blog Posts

  • Liquidia: Exciting New Clinical Trial in Pulmonary Arterial Hypertension April 19, 2018
  • Pulmonary Arterial Hypertension Research March 21, 2018
  • Pulmonary Arterial Hypertension Life Expectancy & Survival Rates March 16, 2018

Categories

Archives

Copyright © 2018 Inspire Pulmonary Media, LLC